References
1. Peyronnet V, Sibiude J, Deruelle P, Huissoud C, Lescure X, Lucet J-C,
et al. Infection par le SARS-CoV-2 chez les femmes enceintes. État des
connaissances et proposition de prise en charge. CNGOF. Gynécologie
Obstétrique Fertil Sénologie [Internet]. 2020 Mar 19 [cited 2020
Mar 30]; Available from:
http://www.sciencedirect.com/science/article/pii/S2468718920301100
2. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical
characteristics and intrauterine vertical transmission potential of
COVID-19 infection in nine pregnant women: a retrospective review of
medical records. The Lancet [Internet]. 2020 Mar 7 [cited 2020 Apr
2];395(10226):809–15. Available from:
http://www.sciencedirect.com/science/article/pii/S0140673620303603
3. Safe Delivery for COVID‐19 Infected Pregnancies - Qi - - BJOG: An
International Journal of Obstetrics & Gynaecology - Wiley Online
Library [Internet]. [cited 2020 Apr 2]. Available from:
https://obgyn-onlinelibrary-wiley-com.sirius.parisdescartes.fr/doi/abs/10.1111/1471-0528.16231
4. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features
and obstetric and neonatal outcomes of pregnant patients with COVID-19
in Wuhan, China: a retrospective, single-centre, descriptive study.
Lancet Infect Dis [Internet]. 2020 Mar 24 [cited 2020 Mar 30];
Available from:
http://www.sciencedirect.com/science/article/pii/S1473309920301766
5. Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB,
et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and
zoonotic coronaviruses. Sci Transl Med [Internet]. 2017 Jun 28
[cited 2020 Apr 1];9(396). Available from:
https://stm-sciencemag-org.sirius.parisdescartes.fr/content/9/396/eaal3653
6. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and
chloroquine effectively inhibit the recently emerged novel coronavirus
(2019-nCoV) in vitro. Cell Res [Internet]. 2020 Mar [cited 2020
Apr 1];30(3):269–71. Available from:
http://www.nature.com/articles/s41422-020-0282-0
7. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et
al. First Case of 2019 Novel Coronavirus in the United States. N Engl J
Med [Internet]. 2020 Mar 5 [cited 2020 Apr 1];382(10):929–36.
Available from: https://doi.org/10.1056/NEJMoa2001191
8. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro
Antiviral Activity and Projection of Optimized Dosing Design of
Hydroxychloroquine for the Treatment of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis [Internet].
[cited 2020 Apr 1]; Available from:
https://academic-oup-com.sirius.parisdescartes.fr/cid/advance-article/doi/10.1093/cid/ciaa237/5801998
9. Colson P, Rolain J-M, Raoult D. Chloroquine for the 2019 novel
coronavirus SARS-CoV-2. Int J Antimicrob Agents [Internet]. 2020 Mar
1 [cited 2020 Apr 1];55(3):105923. Available from:
http://www.sciencedirect.com/science/article/pii/S0924857920300662
10. CHEN Jun LD, CHEN Jun LD. A pilot study of hydroxychloroquine in
treatment of patients with common coronavirus disease-19 (COVID-19). J
Zhejiang Univ Med Sci [Internet]. 2020 Mar 6 [cited 2020 Apr
1];49(1):0–0. Available from:
http://www.zjujournals.com/med/EN/abstract/abstract41137.shtml
11. Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A Trial of
Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl
J Med [Internet]. 2020 Mar 18 [cited 2020 Apr 1]; Available
from: https://doi.org/10.1056/NEJMoa2001282
12. Khalili JS, Zhu H, Mak A, Yan Y, Zhu Y. Novel coronavirus treatment
with ribavirin: Groundwork for evaluation concerning COVID-19. J Med
Virol [Internet]. [cited 2020 Apr 1];n/a(n/a). Available from:
http://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25798
13. Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J, et al. Early antiviral
treatment contributes to alleviate the severity and improve the
prognosis of patients with novel coronavirus disease (COVID-19). J
Intern Med [Internet]. [cited 2020 Mar 29];n/a(n/a). Available
from: http://onlinelibrary.wiley.com/doi/abs/10.1111/joim.13063
14. Trial of Treatments for COVID-19 in Hospitalized Adults - Full Text
View - ClinicalTrials.gov [Internet]. [cited 2020 Apr 1].
Available from: https://clinicaltrials.gov/ct2/show/NCT04315948
15. Mulangu S, Dodd LE, Davey RT, Tshiani Mbaya O, Proschan M, Mukadi D,
et al. A Randomized, Controlled Trial of Ebola Virus Disease
Therapeutics. N Engl J Med [Internet]. 2019 Dec 12 [cited 2020 Apr
2];381(24):2293–303. Available from:
https://doi.org/10.1056/NEJMoa1910993
16. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and
placebo-controlled study - R A Levy, V S Vilela, M J Cataldo, R C Ramos,
J LMB Duarte, B R Tura, E MN Albuquerque, N R Jesús, 2001
[Internet]. [cited 2020 Apr 2]. Available from:
https://journals-sagepub-com.sirius.parisdescartes.fr/doi/abs/10.1191/096120301678646137
17. Zhang S, Yi C, Li C, Zhang F, Peng J, Wang Q, et al. Chloroquine
inhibits endosomal viral RNA release and autophagy-dependent viral
replication and effectively prevents maternal to fetal transmission of
Zika virus. Antiviral Res [Internet]. 2019 Sep 1 [cited 2020 Apr
2];169:104547. Available from:
http://www.sciencedirect.com/science/article/pii/S016635421930066X
18. Lee SJ, McGready R, Fernandez C, Stepniewska K, Paw MK,
Viladpai-nguen SJ, et al. Chloroquine pharmacokinetics in pregnant and
nonpregnant women with vivax malaria. Eur J Clin Pharmacol
[Internet]. 2008 Jul 2;64(10):987. Available from:
https://doi.org/10.1007/s00228-008-0500-z
19. Tookey PA, Thorne C, Wyk J van, Norton M. Maternal and foetal
outcomes among 4118 women with HIV infection treated with
lopinavir/ritonavir during pregnancy: analysis of population-based
surveillance data from the national study of HIV in pregnancy and
childhood in the United Kingdom and Ireland. BMC Infect Dis
[Internet]. 2015 Dec [cited 2020 Apr 2];16(1):1–11. Available
from:
https://bmcinfectdis-biomedcentral-com.sirius.parisdescartes.fr/articles/10.1186/s12879-016-1400-y
20. The Ribavirin Pregnancy Registry: An Interim Analysis of Potential
Teratogenicity at the Mid-Point of Enrollment. - PubMed - NCBI
[Internet]. [cited 2020 Apr 2]. Available from:
https://www-ncbi-nlm-nih-gov.sirius.parisdescartes.fr/pubmed/28689333
21. ACOG Committee Opinion No. 753: Assessment and Treatment of Pregnant
Women With Suspected or Confirmed Influenza. Obstet Gynecol
[Internet]. 2018 Oct [cited 2020 Apr 4];132(4). Available from:
insights.ovid.com